Chlamydia trachomatis heat shock protein 10 (Chsp10) is associated with chronic genital tract infection with C. trachomatis. Chsp10 is homologous to human chaperonin 10 (Cpn10) and early pregnancy factor (EPF), a form of human Cpn10 that is specifically secreted at the start of pregnancy. We investigated cross-reactions between serum anti-Chsp10 antibodies and anti-EPF antibodies in pregnant and nonpregnant patients. Pregnancy was found to be associated with the presence of anti-EPF antibodies, which are specifically induced in pregnant women with a history of C. trachomatis infection, and with the presence of serum anti-Chsp10 antibodies. We also found that infertility was associated with the presence of anti-Chsp10 and anti-EPF antibodies. The HLA class II haplotype DR8 DQ4 was associated with the presence of anti-Chsp10 antibodies but not of anti-EPF antibodies.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC154954 | PMC |
| http://dx.doi.org/10.1128/cdli.10.3.446-450.2003 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Cross-reactivity between Chlamydia trachomatis heat shock protein 10 and early pregnancy factor.
Clin Diagn Lab Immunol
May 2003
Biobanque de Picardie, 16 rue Fernel, 80000 Amiens, France.
Chlamydia trachomatis heat shock protein 10 (Chsp10) is associated with chronic genital tract infection with C. trachomatis. Chsp10 is homologous to human chaperonin 10 (Cpn10) and early pregnancy factor (EPF), a form of human Cpn10 that is specifically secreted at the start of pregnancy.
View Article and Find Full Text PDFIsolation of antibodies which neutralise the activity of early pregnancy factor.
J Immunol Methods
October 2000
Department of Medical Oncology, St. Vincent's Hospital, Victoria St., Darlinghurst, NSW 2010, Sydney, Australia.
Early pregnancy factor (EPF) is a secreted protein with growth regulatory and immunomodulatory properties. It functions as an autocrine growth factor for tumour cells and as an autocrine or paracrine growth factor for regenerating normal cells. Anti-EPF antibodies have demonstrable anti-tumour activity and, as a result, hybridomas which produce such antibodies are unstable.
View Article and Find Full Text PDFEarly pregnancy factor is required at two important stages of embryonic development in the mouse.
Am J Reprod Immunol
April 2000
University of Queensland, Department of Surgery, Royal Brisbane Hospital, Australia.
Problem: The importance of early pregnancy factor (EPF) at the pre-implantation stage of development (days 1-3 post-coitum [p.c.]) has been previously established in this laboratory.
View Article and Find Full Text PDFPurification and partial characterization of an early pregnancy factor-induced suppressor factor (EPF-S1).
Am J Reprod Immunol
June 1995
University of Queensland, Department of Surgery, Royal Brisbane Hospital, Herston, Australia.
Problem: The immunomodulatory properties of early pregnancy factor (EPF) are mediated through induction of at least two lymphokines, designated EPF-S1 and EPF-S2 (previously estimated M(r) 15,000 and 55,000 respectively). The activity of the former is MHC-restricted while the latter is restricted to a locus (or loci) outside the MHC. The present study established further criteria by which EPF-S1 and EPF-S2 might be distinguished from each other and compared with other suppressor factors.
View Article and Find Full Text PDFA monoclonal antibody to an early pregnancy factor-induced suppressor factor (EPF-S1) disrupts implantation in mice.
Am J Reprod Immunol
March 1995
University of Queensland, Department of Surgery, Royal Birsbane Hospital, Australia.
Problem: The importance of EPF during pregnancy has been established previously but the importance of the EPF-induced suppressor factor EPF-S1 in pregnancy has to date been unaddressed. Investigations were therefore conducted in order to study this.
Method: Monoclonal antibodies to EPF-S1 were produced, and one antibody, designated R2T gamma, was characterized.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!